Latest
Boston Scientific & Related Newswire
6/27/2006 2:25:00 PM | Medtronic drug-eluting stent advancing
Comments:(0) Medtronic reports on the status of several studies on its coronary stent: Patient enrollment is complete in the fourth phase of a study, which compares the Medtronic Endeavor stent to the Boston Scientific Taxus Stent. Both are stents that release medication into the patient's bloodstream. A study is also under way to compare the Endeavor to Johnso...
Read More
6/27/2006 9:31:00 AM | Boston Scientific to recall defective heart devices
Comments:(0) Boston Scientific has issued another recall for its Guidant division, on a variety of cardiac devices: some Insignia, Nexus and Contak Renewal pacemakers; and Ventak Prizm 2, Vitality, and Vitality 2 implantable defibrillators. A defect was found that could lead to premature battery failure. Five malfunctions, but no deaths, have been re...
Read More
6/22/2006 1:45:00 PM | Angiotech shares drop on report of lower stent use
Comments:(0) Contrary to a report in the Wall Street Journal, officials at Angiotech, a company that makes drug preparations for stents, say that the use of drug-coated stents is not declining and that they remain more effective than bare metal stents. The Journal report had stated that hospitals were concerned about the formation of blood clots so had begun to avoid stents such as Boston Scientific Taxus Stent. As Angiotech's stock price declined, its President also declared that it was looking to widen its business and reduce the percentage of revenue coming from that source.
Read More
6/16/2006 7:02:00 AM | Johnson & Johnson to appeal stent ruling
Comments:(0) Boston Scientific has scored a point in their patent war against Johnson & Johnson. The companies are claiming each infringed the patents of the other with regard to various models of stents, wire mesh devices that are placed inside arteries. The latest ruling upholds a previous decision that Johnson & Johnson's Cypher stent infringed Boston Scientific's drug coating patent. More rulings, and appeals of those rulings, are expected.
Read More
6/8/2006 5:03:00 PM | Guidant never sent doctors letter about defibrillator risks
Comments:(0) Guidant considered warning doctors about a malfunction in its implantable defibrillator devices - but decided not to, according to documents. Instead of a warning letter that had been drafted, Guidant sent a routine "product update". Ultimately, Guidant ended up recalling the devices in question, and some pacemakers as well, after at least sev...
Read More
More Boston Scientific News | More Medical Devices News